March 7, 2018 | Israel’s Vectorious Medical Technologies, which developed a miniature implant for left-atrial monitoring to detect heart failure, announced that it raised $9.5 million in a Series B funding round led by Boston-based Broadview Ventures and China’s GEOC, with the participation of Israel-based investors, Globes reported. In November, Vectorious was one of 15 Israeli startups selected to present their tech to the Chinese market at the annual Israeli roadshow in China, an event organized by the Israel Innovation Authority in cooperation with the Chinese Ministry of Science and Technology. The company said the funds will allow it to expand its workforce and conduct clinical trials. Vectorious Medical Technologies founded in 2011 by CEO Oren Goldstein.
Facebook comments